Dr. Luz Elena Cano, MD

Dr. Cano practices at Luz Elena Cano, MD in Newport Beach, California.

Dr. Cano's NPI, 1619993698, was assigned on July 14, 2006. Dr. Cano holds California license A05444.

Dr. Cano's primary practice is Luz Elena Cano, MD, at 359 San Miguel Dr, Newport Beach, CA 92660-7812. The practice phone is (949) 645-5933.

Dr. Cano's primary practice is Luz Elena Cano, MD in Newport Beach, California. Dr. Cano is also affiliated with Hoag Hospital Newport Beach.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cano practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Cano's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Cano is licensed in California.

CMS data shows 601 Medicare services from Dr. Cano across 6 procedure codes in 2024, for 119 Medicare patients. Medicare paid $82,326 for them. Every service was in an office.

CMS counts 119 Medicare patients who saw Dr. Cano in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cano's median patient age at 57, with 57% women.

In 2024, Dr. Cano wrote 1,602 Medicare Part D claims for 157 patients. 67% of them were for generic drugs. CMS names the drug for 1,204 of them, across 47 drugs with 11 or more claims each, at $408,602 in total drug cost. In 2023, CMS named 768 claims across 33 drugs.

Dr. Cano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cano as offering telehealth.

Dmand AI links 29 papers to Dr. Cano, published from 2010 to 2024. 2015 was the busiest year, with 5. The most frequent topics are Colombia, Paracoccidioides and Antifungal Agents. Dr. Cano has published most often in Rev Iberoam Micol. Dr. Cano's most frequent co-authors are Francisco Jose Molina, MD and Joshua D. Nosanchuk, MD.

CMS Open Payments shows 1,561 general payments to Dr. Cano from 87 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. UCB, Inc. paid the most, $3,443.